Bull­ish Amarin dou­bling sales force in fast run-up to the big FDA de­ci­sion on Vas­cepa

Amarin is hir­ing. And that will like­ly get the buzz about this biotech’s near-term fu­ture back in play.

In a state­ment out ear­ly Tues­day, Amarin ex­ecs said they plan to go ahead and get start­ed dou­bling the sales force, re­cruit­ing hun­dreds of new staffers as they gear up for the much-an­tic­i­pat­ed re-launch of Vas­cepa with a block­buster la­bel rewrite hang­ing at the FDA.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER